REL and ovarian carcinoma: To investigate the effect of NF-κB1, c-Rel, and ELK1 on ovarian cancer paclitaxel resistance, we transfected siRNA-NF-κB1-2, siRNA-c-Rel-1, and siRNA-ELK1-2 (siRNA-NC) independently into SKOV3-TR30 cell.